- /
- Supported exchanges /
- NASDAQ /
- GPCR.NASDAQ
Structure Therapeutics Inc. American Depositary Shares (GPCR NASDAQ) stock market data APIs
Structure Therapeutics Inc. American Depositary Shares Financial Data Overview
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. The company's lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. It is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist for apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF); and LTSE-2578, an investigational oral small molecule lysophosphatidic acid 1 receptor antagonist for the treatment of IPF and PPF. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Structure Therapeutics Inc. American Depositary Shares data using free add-ons & libraries
Get Structure Therapeutics Inc. American Depositary Shares Fundamental Data
Structure Therapeutics Inc. American Depositary Shares Fundamental data includes:
- Net Revenue: 0
- EBITDA: -121 844 000
- Earnings Per Share: -2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Structure Therapeutics Inc. American Depositary Shares Earnings data
What’s included:
- Latest Release: 2024-11-15
- EPS/Forecast: -0.1867
Get Structure Therapeutics Inc. American Depositary Shares End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Structure Therapeutics Inc. American Depositary Shares News
We're Not Very Worried About Structure Therapeutics' (NASDAQ:GPCR) Cash Burn Rate
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a new ...
Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity
Structure Therapeutics Inc. Preclinical studies with ACCG-2671 demonstrate potent target engagement, robust weight loss, favorable safety profile and PK properties supportive of once-daily dosing in ...
Is Structure Therapeutics Inc. (GPCR) the Best Weight Loss Stock to Buy Now According to Hedge Funds?
We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds.In this article, we are going to take a look at where Structure Therapeutics Inc. (NASDAQ:GPCR) stands aga...
Jefferies Predicts Up to ~1000% Surge for These 2 ‘Strong Buy’ Stocks
There’s been something of a sea change in the economic outlook for 2025, in the aftermath of last month’s election. The prospect of a second Trump administration, with his known preference for der...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.